Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Tivantinib

Generic Name: Tivantinib

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₁₉N_₃O_₂

CAS Number: 905854-02-6

Unique Ingredient Identifier: PJ4H73IL17

Overview

Tivantinib has been investigated in Solid Tumors.

Background

Tivantinib has been investigated in Solid Tumors.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)

Phase 2

Terminated

Posted: 2015/11/18

Sponsor:Istituto Oncologico ...

ID:NCT02608411

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Phase 1

Completed

Posted: 2014/05/30

Sponsor:Daiichi Sankyo

ID:NCT02150733

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Phase 1

Completed

Posted: 2014/01/29

Sponsor:

Armando Santoro, MD

ID:NCT02049060

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)

Phase 3

Completed

Posted: 2014/01/07

Sponsor:Kyowa Kirin Co., Ltd...

ID:NCT02029157

Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects

Phase 2

Completed

Posted: 2013/07/04

Sponsor:

Armando Santoro, MD

ID:NCT01892527

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy